LAURUS LABS LIMITED (540222) — Latest Corporate Announcements
₹2,023.9
₹-45.30 (-2.19%)
Market Cap
₹1,09,353.79 Cr
P/E Ratio
100.04
52W Range
₹864.7 – ₹2065.2
Corporate Actions & Regulatory Filings
Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Laurus Labs Ltd - 540222 - Closure of Trading Window
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Investor Presentation
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended December 31, 2025
To consider and approve the financial results for the period ended September 30, 2025 and dividend
To consider and approve the financial results for the period ended Jun 30, 2025
To consider and approve the financial results for the period ended March 31, 2025 and dividend
To consider and approve the financial results for the period ended December 31, 2024
To consider and approve the financial results for the period ended September 30, 2024 and dividend
To consider and approve the financial results for the period ended Jun 30, 2024
To consider and approve the financial results for the period ended March 31, 2024 and dividend
To consider and approve the financial results for the period ended December 31, 2023
To consider and approve the financial results for the period ended September 30, 2023 and dividend
To consider and approve the financial results for the period ended Jun 30, 2023
To consider and approve the financial results for the period ended March 31, 2023 and dividend
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 24-Jul-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 |
| Year Ended 31-Mar-2026 (Q4 FY26) | 30-Apr-2026 | Declared | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 23-Jan-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 23-Oct-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 and dividend |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 25-Jul-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 24-Apr-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 24-Jan-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 24-Oct-2024 | Declared | To consider and approve the financial results for the period ended September 30, 2024 and dividend |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 25-Jul-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) | 25-Apr-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 24-Jan-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 |
| Quarter Ended 30-Sep-2023 (Q2 FY24) | 20-Oct-2023 | Declared | To consider and approve the financial results for the period ended September 30, 2023 and dividend |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about LAURUS LABS LIMITED BSE Disclosures
What is the latest BSE announcement by LAURUS LABS LIMITED?
The latest BSE disclosure by LAURUS LABS LIMITED (LAURUSLABS), filed on 2026-10-09T19:58:44, is: "Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018". Bsenexus tracks every official filing for LAURUS LABS LIMITED with AI-powered summaries on its announcements feed.
When is LAURUS LABS LIMITED's next board meeting?
No upcoming board meeting is currently tracked for LAURUS LABS LIMITED. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.
When does LAURUS LABS LIMITED declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. LAURUS LABS LIMITED's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.